# Dare Bioscience, Inc.: Form 8-K, filed Apr 22, 2026

- Company: [Dare Bioscience, Inc.](/companies/dare.md) (CIK 1401914)
- Form: 8-K
- Filed: 2026-04-22
- Accepted by EDGAR: Apr 22, 2026, 09:00 ET
- Period: 2026-04-22
- Accession: 0001493152-26-018460
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1401914/000149315226018460/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1401914/000149315226018460/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1401914/000149315226018460/form8-k.htm

Filed Apr 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-018460. Last ingested by Listed: Oct 27, 2026, 17:00 ET. No prices; not investment advice.